Clinical Trial Update: Second Line Chemotherapy for Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating second-line chemotherapy in patients with advanced pancreatic adenocarcinoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: COMPLETED